When to control endemic infections by focusing on high-risk groups

Epidemiology

Volumn 16, Issue 5, 2005, Pages 621-627

  Koopman, James S ^a,b   Simon, Carl P ^a   Riolo, Chris P ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Department of Epidemiology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPARTMENT MODEL; DISEASE TRANSMISSION; ENDEMIC DISEASE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION; INFECTION CONTROL; INFECTION SENSITIVITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; VACCINATION;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; DISEASE SUSCEPTIBILITY; ENDEMIC DISEASES; HUMANS; INCIDENCE; MODELS, STATISTICAL; RISK ASSESSMENT; TIME FACTORS;

EID: 24144490356     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ede.0000172133.46385.18     Document Type: Article

References (23)

1. Haddix AC, Teutsch SM, Shaffer PA, Dunet DO. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation. New York: Oxford University Press; 1996.
2. Rose G. Sick individuals and sick populations. Int J Epidemiol. 2001; 30:427-432; discussion 433-434.
3. Koopman J. Modeling infection transmission. Annu Rev Public Health. 2004;25:303-326.
4. Koopman JS, Weed DL. Epigenesis theory: a mathematical model relating causal concepts of pathogenesis in individuals to disease patterns in populations. Am J Epidemiol. 1990;132:366-390.
5. Jacquez JA, Koopman JS, Simon CP, Longini IM Jr. Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immun Defic Syndr. 1994;7:1169-1184.
6. Koopman JS, Jacquez JA, Welch GW, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immun Defic Syndr Hum Retrovirol. 1997;14:249-258.
7. Adams AL, Chick SE, Barth-Jones DC, Koopman JS. Stimulation to evaluate HIV vaccine trial designs. Simulation. 1998;714:228-241.
8. Datta S, Halloran ME, Longini IM Jr. Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacy. Stat Med. 1998;17:185-200.
9. Datta S, Halloran ME, Longini IM Jr. Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus household. Biometrics. 1999;55:792-798.
10. Halloran ME, Struchiner CJ, Longini IM Jr. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol. 1997;146:789-803.
11. Halloran ME, Longini IM Jr, Struchiner CJ. Design and interpretation of vaccine field studies. Epidemiol Rev. 1999;21:73-88.
12. Halloran ME, Longini IM Jr. Using validation sets for outcomes and exposure to infection in vaccine field studies. Am J Epidemiol. 2001; 154:391-398.
13. Koopman JS, Little RJ. Assessing HIV vaccine effects. Am J Epidemiol. 1995;142:1113-1120.
14. Longini IM Jr, Datta S, Halloran ME. Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. J Acquir Immun Defic Syndr Hum Retrovirol. 1996;13:440-447.
15. Longini IM Jr, Sagatelian K, Rida WN, Halloran ME. Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations [erratum appears in Stat Med. 1999;18:890]. Stat Med. 1998;17:1121-1136.
16. Longini IM Jr, Hudgens MG, Halloran ME, Sagatelian K. A Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines. Stat Med. 1999;18:53-68.
17. Longini IM Jr, Halloran ME, Nizam A. Model-based estimation of vaccine effects from community vaccine trials. Stat Med. 2002;21:481-495.
18. Koopman JS, Lin X, Chick SE, Gilsdorf JR. Transmission model analysis of non-typeable Haemophilus influenzae. In: Brandeau ML, Pierskalla B, Sainfort F, eds. Handbook of Operations Research/Management Science Applications in Health Care. Kluwer; 2003:1-32.
19. Chick SE, Koopman JS, Soorapanth S, Brown ME. Infection transmission system models for microbial risk assessment. Sci Total Environ. 2001;274:197-207.
20. Soorapanth S, Chick SE, Koopman JS. Simulation of stochastic infection transmission models designed to inform water treatment decisions. In: Giambiasi N, Frydman C, eds. Proceedings of the European Simulation Symposium Society for Computer Simulation. 2001;517-521.
21. Koopman JS, Chick SE, Simon CP, Riolo CS, Jacquez G. Stochastic effects on endemic infection levels of disseminating versus local contacts. Math Biosci. 2002;180:49-71.
22. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford University Press; 1991.
23. Woolhouse ME, Dye C, Etard JF, et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci USA. 1997;94:338-342.